Axogen (AXGN) Total Non-Current Liabilities (2017 - 2026)

Axogen's (AXGN) quarterly Total Non-Current Liabilities came in at $44.5 million in Q1 2026, down 50.87% year-on-year from $90.7 million in Q1 2025, and down 49.93% quarter-over-quarter from $89.0 million in Q4 2025.

Axogen (AXGN) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

Axogen's Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $44.5 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 50.87% year-over-year to $44.5 million in Q1 2026; TTM through Mar 2026 was $44.5 million, a 50.87% decrease from a year earlier, with the FY2025 full-year figure at $89.0 million, down 10.8% from the prior year.
  • Total Non-Current Liabilities declined to $44.5 million in Q1 2026 per AXGN's latest filing, from $89.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $99.7 million in Q4 2024 and bottomed at $44.5 million in Q1 2026.
  • The 5-year median for Total Non-Current Liabilities is $90.2 million (2023), against an average of $88.7 million.
  • Across the five-year window, Total Non-Current Liabilities gained 18.26% in 2022 and sank 50.87% in 2026, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $89.9 million in 2022, then advanced by 9.24% to $98.2 million in 2023, then rose by 1.58% to $99.7 million in 2024, then retreated by 10.8% to $89.0 million in 2025, then plunged by 49.93% to $44.5 million in 2026.
  • Per Business Quant, the three latest AXGN Total Non-Current Liabilities figures stand at $44.5 million (Q1 2026), $89.0 million (Q4 2025), and $95.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Axogen 2.05 Bn 1.95 Bn 46.19 Mn 44.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.54 Mn
Dec 31, 2025 88.95 Mn
Sep 30, 2025 95.45 Mn
Jun 30, 2025 91.10 Mn
Mar 31, 2025 90.66 Mn
Dec 31, 2024 99.73 Mn
Sep 30, 2024 90.13 Mn
Jun 30, 2024 90.79 Mn
Mar 31, 2024 90.44 Mn
Dec 31, 2023 98.18 Mn
Sep 30, 2023 92.95 Mn
Jun 30, 2023 90.22 Mn
Mar 31, 2023 87.26 Mn
Dec 31, 2022 89.87 Mn
Sep 30, 2022 89.67 Mn
Jun 30, 2022 89.52 Mn
Mar 31, 2022 88.86 Mn
Dec 31, 2021 89.91 Mn
Sep 30, 2021 94.69 Mn
Jun 30, 2021 89.87 Mn